Cumberland Pharmaceuticals (CPIX) vs OnKure Therapeutics (OKUR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cumberland Pharmaceuticals (CPIX) has outperformed OnKure Therapeutics (OKUR) over the past year, gaining 93.5% versus a loss of 21.4%. Over five years, CPIX leads with a +151.5% price change compared with -96.4% for OKUR. Cumberland Pharmaceuticals is the larger company by market cap ($103.2 million vs $95.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CPIX | OKUR |
|---|---|---|
| Share price | $6.89 | $2.35 |
| Market cap | $103.23M | $95.17M |
| 1-day change | -3.50% | -4.47% |
| YTD return | +73.12% | -18.97% |
| 1-year return | +93.54% | -21.40% |
| 5-year return | +151.46% | -96.35% |
| Forward P/E | 49.21 | — |
| EPS (TTM) | $-0.62 | $-2.90 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.28 | $5.38 |
| 52-week low | $1.85 | $2.23 |
| Distance from 52-week high | -25.75% | -56.32% |
| Average volume | 87.97K | 210.66K |
| Shares outstanding | 14.98M | 40.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CPIX has outperformed OKUR by 114.9 percentage points over the past year.
CPIX vs OKUR FAQ
Which is bigger, Cumberland Pharmaceuticals or OnKure Therapeutics?
Cumberland Pharmaceuticals (CPIX) is larger, with a market capitalization of $103.23M compared with $95.17M for OnKure Therapeutics (OKUR).
Which stock has performed better over the past year, CPIX or OKUR?
CPIX returned +93.54% over the past 12 months, compared with -21.40% for OKUR (price return, excluding dividends). Past performance does not predict future results.
Are Cumberland Pharmaceuticals and OnKure Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.